Your browser doesn't support javascript.
loading
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer.
Hakenberg, Oliver W; Perez-Gracia, Jose Luis; Castellano, Daniel; Demkow, Tomasz; Ali, Tarek; Caffo, Orazio; Heidenreich, Axel; Schultze-Seemann, Wolfgang; Sautois, Brieuc; Pavlik, Ivan; Qin, Amy; Novosiadly, Ruslan D; Shahir, Ashwin; Ilaria, Robert; Nippgen, Johannes.
Afiliação
  • Hakenberg OW; Department of Urologie, Universitätsmedizin Rostock, Rostock, Germany. Electronic address: oliver.hakenberg@med.uni-rostock.de.
  • Perez-Gracia JL; Clinica Universidad De Navarra, Pamplona, Spain. Electronic address: jlgracia@unav.es.
  • Castellano D; Medical Oncology Department (CiberOnc), Hospital 12 De Octubre, Madrid, Spain. Electronic address: cdanicas@hotmail.com.
  • Demkow T; Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. Electronic address: demkow@coi.waw.pl.
  • Ali T; Department of Urology, Josa Andras Teaching Hospital, Nyiregyhaza, Hungary. Electronic address: tarekali@freemail.hu.
  • Caffo O; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy. Electronic address: orazio.caffo@apss.tn.it.
  • Heidenreich A; Department of Urology and Uro-Oncology, University Hospital Cologne, Cologne, Germany. Electronic address: axel.heidenreich@uk-koeln.de.
  • Schultze-Seemann W; Department of Urology, University of Freiburg, Freiburg, Germany. Electronic address: wolfgang.schultze-seemann@uniklinik-freiburg.de.
  • Sautois B; CHU Sart Tilman, University of Liège, Liège, Belgium. Electronic address: brieuc.sautois@chu.ulg.ac.be.
  • Pavlik I; Department of Urology, General University Hospital, And First Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: ivan.pavlik@vfn.cz.
  • Qin A; Eli Lilly and Company, Bridgewater, NJ, USA. Electronic address: aqin@dsi.com.
  • Novosiadly RD; Eli Lilly and Company, NY, USA. Electronic address: ruslan.novosiadly@lilly.com.
  • Shahir A; Eli Lilly and Company, Basingstoke, United Kingdom. Electronic address: shahir_ashwin@lilly.com.
  • Ilaria R; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: cancerdoc@mac.com.
  • Nippgen J; Eli Lilly and Company, Bridgewater, NJ, USA. Electronic address: dr.nippgen@web.de.
Eur J Cancer ; 107: 186-195, 2019 01.
Article em En | MEDLINE | ID: mdl-30573277
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article